Suppr超能文献

新型无动物蛋白培养基 MDSS2N 支持细胞生长和各种病毒的生产。

The new medium MDSS2N, free of any animal protein supports cell growth and production of various viruses.

机构信息

Laboratoire de Technologie Cellulaire, Institut Pasteur, 25, rue du Docteur Roux, F-75724, Paris Cedex 15, France.

出版信息

Cytotechnology. 1999 Jul;30(1-3):191-201. doi: 10.1023/A:1008021317639.

Abstract

The development of media free of serum and animal or human proteins is of utmost importance for increasing the safety of biologicals produced for therapy and vaccination. In order to reduce the risk of contamination, we have modified the serum free medium MDSS2, a very efficient serum free medium for the production of various biologicals including experimental vaccines using different cell lines (Merten et al., 1994), by replacing the animal derived products by plant extracts. The new serum and animal protein free medium (MDSS2N) can be efficiently used for biomass production of various cell lines. These cells grow equally well or better in this new serum-free medium than in the old formulation (MDSS2):* BHK-21/BRS cells, adapted to MDSS2N, showed an overall specific growth rate of 0.0197 h-1 (mu_max = 0.0510+/-0.0058 h-1), whereas those cultivated in MDSS2 grew with an average specific growth rate of 0.0179 h-1 (mu_max = 0.0305+/-0.0177 h-1).* Vero cells grew with an average specific growth rate of 0.0159 h-1 and 0.0153 h-1 in MDSS2 and MDSS2N, respectively. Very similar growth rates were obtained in microcarrier cultures in stirred tank reactors: the specific growth rates were 0.0161 h-1 and 0.0166 h-1 for MDSS2 and MDSS2N cultures, respectively.* For MDCK cells, when cultured on microcarriers in bioreactors, a higher average specific growth rate was observed in MDSS2N than in MDSS2; values of 0.0248 h-1 and 0.0168 h-1, respectively, were obtained.The capacity of MDSS2N to support the production of different viruses was equally evaluated and it could be established that for certain viruses there are no or insignificant differences between MDSS2N and MDSS2 (influenza and polio virus), whereas, the production of rabies virus is somewhat reduced in MDSS2N when compared to MDSS2. The use of MDSS2N for cell culture and the production of various viruses is discussed.

摘要

为提高治疗和疫苗用生物制剂的安全性,开发无血清和动物或人蛋白的培养基至关重要。为了降低污染风险,我们对非常高效的无血清培养基 MDSS2 进行了改良,该培养基可用于生产各种生物制剂,包括使用不同细胞系的实验性疫苗(Merten 等人,1994 年),方法是用植物提取物替代动物源性产品。新的无血清和无动物蛋白培养基(MDSS2N)可有效地用于各种细胞系的生物量生产。这些细胞在这种新的无血清培养基中的生长情况与在旧配方(MDSS2)中一样好或更好:* 适应 MDSS2N 的 BHK-21/BRS 细胞的总体比生长速率为 0.0197 h-1(mu_max = 0.0510+/-0.0058 h-1),而在 MDSS2 中培养的细胞的平均比生长速率为 0.0179 h-1(mu_max = 0.0305+/-0.0177 h-1)。* Vero 细胞在 MDSS2 和 MDSS2N 中的平均比生长速率分别为 0.0159 h-1 和 0.0153 h-1。在搅拌釜式反应器中的微载体培养中获得了非常相似的生长速率:MDSS2 和 MDSS2N 培养物的比生长速率分别为 0.0161 h-1 和 0.0166 h-1。* 对于 MDCK 细胞,在生物反应器中的微载体上培养时,在 MDSS2N 中观察到的平均比生长速率高于 MDSS2;分别获得 0.0248 h-1 和 0.0168 h-1 的值。还评估了 MDSS2N 支持生产不同病毒的能力,可以确定对于某些病毒,MDSS2N 和 MDSS2 之间没有差异或差异不大(流感病毒和脊髓灰质炎病毒),而狂犬病病毒的产量在 MDSS2N 中与 MDSS2 相比略有降低。讨论了 MDSS2N 在细胞培养和各种病毒生产中的应用。

相似文献

引用本文的文献

5
Safety for vaccine(e)s.疫苗的安全性。
Cytotechnology. 2000 Nov;34(3):181-3. doi: 10.1023/A:1008160817560.
7
The role of recombinant proteins in the development of serum-free media.重组蛋白在无血清培养基开发中的作用。
Cytotechnology. 2006 Mar;50(1-3):49-56. doi: 10.1007/s10616-006-9002-y. Epub 2006 Aug 5.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验